{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:45:51Z","timestamp":1783557951877,"version":"3.55.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T00:00:00Z","timestamp":1592438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T00:00:00Z","timestamp":1592438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s00520-020-05554-2","type":"journal-article","created":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T14:04:00Z","timestamp":1592489040000},"page":"4627-4644","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["A systematic review of the impact of contemporary treatment modalities for cervical cancer on women\u2019s self-reported health-related quality of life"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3483-4241","authenticated-orcid":false,"given":"L. M.","family":"Wiltink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. S.","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Pendlebury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Pittman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Mileshkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Mercieca-Bebber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.-A.","family":"Tait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Rutherford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,18]]},"reference":[{"issue":"6","key":"5554_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394\u2013424","journal-title":"CA Cancer J Clin"},{"key":"5554_CR2","unstructured":"Noone AM, H N, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds) (2018) SEER Cancer Statistics Review, 1975-2015, National Cancer Institute. Bethesda, MD, https:\/\/seer.cancer.gov\/csr\/1975_2015\/, based on November 2017 SEER data submission, posted to the SEER web site"},{"issue":"suppl_4","key":"5554_CR3","doi-asserted-by":"crossref","first-page":"iv72","DOI":"10.1093\/annonc\/mdx220","volume":"28","author":"C Marth","year":"2017","unstructured":"Marth C et al (2017) Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up\u2020. Ann Oncol 28(suppl_4):iv72\u2013iv83","journal-title":"Ann Oncol"},{"issue":"10167","key":"5554_CR4","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0140-6736(18)32470-X","volume":"393","author":"PA Cohen","year":"2019","unstructured":"Cohen PA, Jhingran A, Oaknin A, Denny L (2019) Cervical cancer. Lancet 393(10167):169\u2013182","journal-title":"Lancet"},{"issue":"Suppl 2","key":"5554_CR5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ijgo.12611","volume":"143","author":"N Bhatla","year":"2018","unstructured":"Bhatla N et al (2018) Cancer of the cervix uteri. Int J Gynaecol Obstet 143(Suppl 2):22\u201336","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"5554_CR6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ijgo.12749","volume":"145","author":"N Bhatla","year":"2019","unstructured":"Bhatla N et al (2019) Revised FIGO staging for carcinoma of the cervix uteri. Int J Gynaecol Obstet 145(1):129\u2013135","journal-title":"Int J Gynaecol Obstet"},{"key":"5554_CR7","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ejogrb.2018.06.032","volume":"228","author":"K Shimamoto","year":"2018","unstructured":"Shimamoto K, Saito T, Kitade S, Tomita Y, Nagayama R, Yamaguchi S, Ariyoshi K, Okadome M (2018) A study of treatments and outcomes in elderly women with cervical cancer. Eur J Obstet Gynecol Reprod Biol 228:174\u2013179","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"5554_CR8","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1200\/JCO.1994.12.3.608","volume":"12","author":"D Osoba","year":"1994","unstructured":"Osoba D (1994) Lessons learned from measuring health-related quality of life in oncology. J Clin Oncol 12(3):608\u2013616","journal-title":"J Clin Oncol"},{"key":"5554_CR9","doi-asserted-by":"publisher","unstructured":"Rutherford C, M-B R., Tait M, Mileshkin L, King M (2017) Quality of life in cervical cancer. In: Farghaly S (editor) Uterine cervical cancer: clinical and therapeautic perspectives. Springer, New York. https:\/\/doi.org\/10.1007\/978-3-030-02701-8 [ISBN (Print): 978-3-030-02700-1; ISBN (EBook): 978-3-030-02700-1]","DOI":"10.1007\/978-3-030-02701-8"},{"key":"5554_CR10","unstructured":"Food and Drug Administration (2009) Patient reported outcome measures: use in medical product development to support labelling claims. MD: US Department of Health & Human Support Food & Drug Administration"},{"key":"5554_CR11","doi-asserted-by":"crossref","unstructured":"Moher D et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7)","DOI":"10.1371\/journal.pmed.1000097"},{"key":"5554_CR12","volume-title":"Standard quality assessment criteria for evaluating primary research papers froma variety of fields","author":"LM Kmet","year":"2004","unstructured":"Kmet LM, Lee RC, Cook LS (2004) Standard quality assessment criteria for evaluating primary research papers froma variety of fields. Alberta Heritage Foundation for Medical Research, Edmonton"},{"issue":"8","key":"5554_CR13","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1001\/jama.2013.879","volume":"309","author":"MP Calvert","year":"2013","unstructured":"Calvert MP et al (2013) Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension. JAMA 309(8):814\u2013822","journal-title":"JAMA"},{"issue":"12","key":"5554_CR14","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1111\/jsm.12702","volume":"11","author":"G Bogani","year":"2014","unstructured":"Bogani G, Serati M, Nappi R, Cromi A, di Naro E, Ghezzi F (2014) Nerve-sparing approach reduces sexual dysfunction in patients undergoing laparoscopic radical hysterectomy. J Sex Med 11(12):3012\u20133020","journal-title":"J Sex Med"},{"issue":"2","key":"5554_CR15","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ygyno.2010.07.016","volume":"119","author":"J Carter","year":"2010","unstructured":"Carter J, Sonoda Y, Baser RE, Raviv L, Chi DS, Barakat RR, Iasonos A, Brown CL, Abu-Rustum NR (2010) A 2-year prospective study assessing the emotional, sexual, and quality of life concerns of women undergoing radical trachelectomy versus radical hysterectomy for treatment of early-stage cervical cancer. Gynecol Oncol 119(2):358\u2013365","journal-title":"Gynecol Oncol"},{"issue":"4","key":"5554_CR16","first-page":"490","volume":"7","author":"I Conic","year":"2012","unstructured":"Conic I et al (2012) Anxiety levels related to the type of therapy for cervical cancer. Central Eur J Med 7(4):490\u2013496","journal-title":"Central Eur J Med"},{"issue":"4","key":"5554_CR17","doi-asserted-by":"crossref","first-page":"E18","DOI":"10.1097\/NCC.0b013e31826d2ef4","volume":"36","author":"Y Ding","year":"2013","unstructured":"Ding Y, Hu Y, Hallberg IR (2013) Health-related quality of life and associated factors in Chinese women with cervical cancer: a 9-month follow-up. Cancer Nurs 36(4):E18\u2013E26","journal-title":"Cancer Nurs"},{"issue":"10","key":"5554_CR18","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1016\/j.clinthera.2015.08.018","volume":"37","author":"GC Du Toit","year":"2015","unstructured":"Du Toit GC, Kidd M (2015) Prospective quality of life study of south African women undergoing treatment for advanced-stage cervical cancer. Clin Ther 37(10):2324\u20132331","journal-title":"Clin Ther"},{"issue":"3","key":"5554_CR19","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ygyno.2011.09.041","volume":"124","author":"G Ferrandina","year":"2012","unstructured":"Ferrandina G, Mantegna G, Petrillo M, Fuoco G, Venditti L, Terzano S, Moruzzi C, Lorusso D, Marcellusi A, Scambia G (2012) Quality of life and emotional distress in early stage and locally advanced cervical cancer patients: a prospective, longitudinal study. Gynecol Oncol 124(3):389\u2013394","journal-title":"Gynecol Oncol"},{"issue":"2","key":"5554_CR20","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ygyno.2004.04.025","volume":"94","author":"S Hawighorst-Knapstein","year":"2004","unstructured":"Hawighorst-Knapstein S, Fusshoeller C, Franz C, Trautmann K, Schmidt M, Pilch H, Schoenefuss G, Georg Knapstein P, Koelbl H, Kelleher DK, Vaupel P (2004) The impact of treatment for genital cancer on quality of life and body image - results of a prospective longitudinal 10-year study. Gynecol Oncol 94(2):398\u2013403","journal-title":"Gynecol Oncol"},{"issue":"2","key":"5554_CR21","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ygyno.2017.08.009","volume":"147","author":"ST Heijkoop","year":"2017","unstructured":"Heijkoop ST, Nout RA, Quint S, Mens JWM, Heijmen BJM, Hoogeman MS (2017) Dynamics of patient reported quality of life and symptoms in the acute phase of online adaptive external beam radiation therapy for locally advanced cervical cancer. Gynecol Oncol 147(2):439\u2013449","journal-title":"Gynecol Oncol"},{"key":"5554_CR22","doi-asserted-by":"crossref","unstructured":"Jiang H et al (2016) Vaginal extension improves sexual function in patients receiving laparoscopic radical hysterectomy. Gynecol Oncol 27","DOI":"10.1016\/j.ygyno.2016.04.007"},{"issue":"3","key":"5554_CR23","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ygyno.2019.07.005","volume":"154","author":"B Liu","year":"2019","unstructured":"Liu B, Li L, Wang M, Wei L, Li J, Zou W, Lv Y, Zhang H, Liu S (2019) Health-related quality of life in locally advanced cervical cancer patients treated with neoadjuvant therapy followed by radical surgery: a single-institutional retrospective study from a prospective database. Gynecol Oncol 154(3):583\u2013589","journal-title":"Gynecol Oncol"},{"key":"5554_CR24","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1471-2407-13-127","volume":"13","author":"G Mantegna","year":"2013","unstructured":"Mantegna G, Petrillo M, Fuoco G, Venditti L, Terzano S, Anchora LP, Scambia G, Ferrandina G (2013) Long-term prospective longitudinal evaluation of emotional distress and quality of life in cervical cancer patients who remained disease-free 2-years from diagnosis. BMC Cancer 13:127","journal-title":"BMC Cancer"},{"issue":"9","key":"5554_CR25","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1097\/IGC.0b013e3182a80a65","volume":"23","author":"QD Pieterse","year":"2013","unstructured":"Pieterse QD, Kenter GG, Maas CP, de Kroon CD, Creutzberg CL, Trimbos JBMZ, ter Kuile MM (2013) Self-reported sexual, bowel and bladder function in cervical cancer patients following different treatment modalities: longitudinal prospective cohort study. Int J Gynecol Cancer 23(9):1717\u20131725","journal-title":"Int J Gynecol Cancer"},{"issue":"8","key":"5554_CR26","first-page":"12044","volume":"10","author":"H He","year":"2017","unstructured":"He H et al (2017) Laparoscopic radical surgery in early-stage cervical cancer: short-term and long-term outcomes and survival analysis. Int J Clin Exp Med 10(8):12044\u201312055","journal-title":"Int J Clin Exp Med"},{"issue":"1","key":"5554_CR27","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejon.2011.03.001","volume":"16","author":"E Barnas","year":"2012","unstructured":"Barnas E et al (2012) The quality of life of women treated for cervical cancer. Eur J Oncol Nurs 16(1):59\u201363","journal-title":"Eur J Oncol Nurs"},{"issue":"3","key":"5554_CR28","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.ygyno.2016.10.012","volume":"143","author":"ND Fleming","year":"2016","unstructured":"Fleming ND, Ramirez PT, Soliman PT, Schmeler KM, Chisholm GB, Nick AM, Westin SN, Frumovitz M (2016) Quality of life after radical trachelectomy for early-stage cervical cancer: a 5-year prospective evaluation. Gynecol Oncol 143(3):596\u2013603","journal-title":"Gynecol Oncol"},{"issue":"3","key":"5554_CR29","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.radonc.2018.05.002","volume":"127","author":"L Fokdal","year":"2018","unstructured":"Fokdal L, P\u00f6tter R, Kirchheiner K, Lindegaard JC, Jensen NBK, Kirisits C, Chargari C, Mahantshetty U, J\u00fcrgenliemk-Schulz IM, Segedin B, Hoskin P, Tanderup K (2018) Physician assessed and patient reported urinary morbidity after radio-chemotherapy and image guided adaptive brachytherapy for locally advanced cervical cancer. Radiother Oncol 127(3):423\u2013430","journal-title":"Radiother Oncol"},{"issue":"3","key":"5554_CR30","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.radonc.2018.05.016","volume":"127","author":"NBK Jensen","year":"2018","unstructured":"Jensen NBK, P\u00f6tter R, Kirchheiner K, Fokdal L, Lindegaard JC, Kirisits C, Mazeron R, Mahantshetty U, J\u00fcrgenliemk-Schulz IM, Segedin B, Hoskin P, Tanderup K, EMBRACE Collaborative Group (2018) Bowel morbidity following radiochemotherapy and image-guided adaptive brachytherapy for cervical cancer: physician- and patient reported outcome from the EMBRACE study. Radiother Oncol 127(3):431\u2013439","journal-title":"Radiother Oncol"},{"issue":"2","key":"5554_CR31","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ijrobp.2014.02.018","volume":"89","author":"K Kirchheiner","year":"2014","unstructured":"Kirchheiner K, Czajka-Pepl A, Ponocny-Seliger E, Scharbert G, Wetzel L, Nout RA, Sturdza A, Dimopoulos JC, D\u00f6rr W, P\u00f6tter R (2014) Posttraumatic stress disorder after high-dose-rate brachytherapy for cervical cancer with 2 fractions in 1 application under spinal\/epidural anesthesia: incidence and risk factors. Int J Radiat Oncol Biol Phys 89(2):260\u2013267","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"5554_CR32","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ygyno.2014.10.031","volume":"136","author":"K Kirchheiner","year":"2015","unstructured":"Kirchheiner K, Nout RA, Czajka-Pepl A, Ponocny-Seliger E, Sturdza AE, Dimopoulos JC, D\u00f6rr W, P\u00f6tter R (2015) Health related quality of life and patient reported symptoms before and during definitive radio(chemo)therapy using image-guided adaptive brachytherapy for locally advanced cervical cancer and early recovery - a mono-institutional prospective study. Gynecol Oncol 136(3):415\u2013423","journal-title":"Gynecol Oncol"},{"issue":"5","key":"5554_CR33","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.ijrobp.2015.12.363","volume":"94","author":"K Kirchheiner","year":"2016","unstructured":"Kirchheiner K, P\u00f6tter R, Tanderup K, Lindegaard JC, Haie-Meder C, Petri\u010d P, Mahantshetty U, J\u00fcrgenliemk-Schulz IM, Rai B, Cooper R, D\u00f6rr W, Nout RA, Lindegaard J, Tanderup K, Fokdal L, van der Steen Banasik E, Haie-Meder C, Dumas I, Chargari C, Nout RA, van Limbergen E, Petri\u010d P, Segedin B, Hudej R, Erickson B, Hoskin P, Lowe G, Mahantshetty U, Swamidas J, Shrivastava SK, J\u00fcrgenliemk-Schulz IM, de Leeuw A, Kirchheiner K, D\u00f6rr W, P\u00f6tter R, Lutgens LCHW, Hadjiev J, Cooper R, Bownes P, Sundset M, Bruheim K, Hellebust TP, Huang F, Menon G, Villafranca E, Rai B, Oinam AS, Tan LT, Bachand F, Jacobson G, Anttila M, Pieters B (2016) Health-related quality of life in locally advanced cervical cancer patients after definitive chemoradiation therapy including image guided adaptive brachytherapy: an analysis from the EMBRACE study. Int J Radiat Oncol Biol Phys 94(5):1088\u20131098","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"5554_CR34","doi-asserted-by":"crossref","first-page":"62","DOI":"10.17305\/bjbms.2011.2628","volume":"11","author":"D Ljuca","year":"2011","unstructured":"Ljuca D, Marosevic G (2011) Impact of chemoradiotherapy on vaginal and sexual function of patients with FIGO IIb cervical cancer. Bosnian J Basic Med Sci 11(1):62\u201364","journal-title":"Bosnian J Basic Med Sci"},{"issue":"3","key":"5554_CR35","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.radonc.2018.03.026","volume":"127","author":"D Najjari Jamal","year":"2018","unstructured":"Najjari Jamal D, P\u00f6tter R, Haie-Meder C, Lindegaard JC, Juergenliemk-Schulz IM, Mahantshetty U, Segedin B, Bruheim K, Hoskin P, Rai B, Wiebe E, Cooper R, Tanderup K, Kirchheiner K, EMBRACE collaborative group (2018) Physician assessed and patient reported lower limb edema after definitive radio(chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: a report from the EMBRACE study. Radiother Oncol 127(3):449\u2013455","journal-title":"Radiother Oncol"},{"issue":"3","key":"5554_CR36","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.radonc.2018.03.009","volume":"127","author":"S Smet","year":"2018","unstructured":"Smet S, P\u00f6tter R, Haie-Meder C, Lindegaard JC, Schulz-Juergenliemk I, Mahantshetty U, Segedin B, Bruheim K, Hoskin P, Rai B, Huang F, Cooper R, van Limbergen E, Tanderup K, Kirchheiner K, EMBRACE Collaborative Group (2018) Fatigue, insomnia and hot flashes after definitive radiochemotherapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: an analysis from the EMBRACE study. Radiother Oncol 127(3):440\u2013448","journal-title":"Radiother Oncol"},{"issue":"3","key":"5554_CR37","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ygyno.2010.08.020","volume":"119","author":"D Cella","year":"2010","unstructured":"Cella D, Huang HQ, Monk BJ, Wenzel L, Benda J, McMeekin DS, Cohn D, Ramondetta L, Boardman CH (2010) Health-related quality of life outcomes associated with four cisplatin-based doublet chemotherapy regimens for stage IVB recurrent or persistent cervical cancer: a Gynecologic Oncology Group study. Gynecol Oncol 119(3):531\u2013537","journal-title":"Gynecol Oncol"},{"issue":"3","key":"5554_CR38","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ygyno.2005.09.023","volume":"100","author":"IHJ Long","year":"2006","unstructured":"Long IHJ et al (2006) Clinical results and quality of life analysis for the MVAC combination (methotrexate, vinblastine, doxorubicin, and cisplatin) in carcinoma of the uterine cervix: a Gynecologic Oncology Group study. Gynecol Oncol 100(3):537\u2013543","journal-title":"Gynecol Oncol"},{"issue":"2","key":"5554_CR39","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ygyno.2005.10.039","volume":"101","author":"RP McQuellon","year":"2006","unstructured":"McQuellon RP, Thaler HT, Cella D, Moore DH (2006) Quality of life (QOL) outcomes from a randomized trial of cisplatin versus cisplatin plus paclitaxel in advanced cervical cancer: a Gynecologic Oncology Group study. Gynecol Oncol 101(2):296\u2013304","journal-title":"Gynecol Oncol"},{"issue":"21","key":"5554_CR40","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1200\/JCO.2005.10.522","volume":"23","author":"BJ Monk","year":"2005","unstructured":"Monk BJ, Huang HQ, Cella D, Long HJ 3rd, Gynecologic Oncology Group Study (2005) Quality of life outcomes from a randomized phase III trial of cisplatin with or without topotecan in advanced carcinoma of the cervix: a Gynecologic Oncology Group Study. J Clin Oncol Off J Am Soc Clin Oncol 23(21):4617\u20134625","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"15","key":"5554_CR41","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1200\/JCO.2004.04.170","volume":"22","author":"DH Moore","year":"2004","unstructured":"Moore DH, Blessing JA, McQuellon RP, Thaler HT, Cella D, Benda J, Miller DS, Olt G, King S, Boggess JF, Rocereto TF (2004) Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol 22(15):3113\u20133119","journal-title":"J Clin Oncol"},{"issue":"3","key":"5554_CR42","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1470-2045(15)70004-5","volume":"16","author":"RT Penson","year":"2015","unstructured":"Penson RT, Huang HQ, Wenzel LB, Monk BJ, Stockman S, Long HJ III, Ramondetta LM, Landrum LM, Oaknin A, Reid TJA, Leitao MM, Method M, Michael H, Tewari KS (2015) Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology-Gynecologic Oncology Group protocol 240). Lancet Oncol 16(3):301\u2013311","journal-title":"Lancet Oncol"},{"issue":"11","key":"5554_CR43","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.ejca.2012.02.059","volume":"48","author":"K Cocks","year":"2012","unstructured":"Cocks K, King MT, Velikova G, de Castro G Jr, Martyn St-James M, Fayers PM, Brown JM (2012) Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. Eur J Cancer 48(11):1713\u20131721","journal-title":"Eur J Cancer"},{"key":"5554_CR44","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1186\/s12889-015-2014-9","volume":"15","author":"JH Kim","year":"2015","unstructured":"Kim JH, Park EC (2015) Impact of socioeconomic status and subjective social class on overall and health-related quality of life. BMC Public Health 15:783","journal-title":"BMC Public Health"},{"key":"5554_CR45","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.maturitas.2016.08.005","volume":"94","author":"MD van Gent","year":"2016","unstructured":"van Gent MD et al (2016) Nerve-sparing radical hysterectomy versus conventional radical hysterectomy in early-stage cervical cancer. A systematic review and meta-analysis of survival and quality of life. Maturitas 94:30\u201338","journal-title":"Maturitas"},{"issue":"5","key":"5554_CR46","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1159\/000443122","volume":"38","author":"Z Xue","year":"2016","unstructured":"Xue Z, Zhu X, Teng Y (2016) Comparison of nerve-sparing radical hysterectomy and radical hysterectomy: a systematic review and meta-analysis. Cell Physiol Biochem 38(5):1841\u20131850","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"5554_CR47","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1757-2215-7-69","volume":"7","author":"K Gubbala","year":"2014","unstructured":"Gubbala K, Laios A, Gallos I, Pathiraja P, Haldar K, Ind T (2014) Outcomes of ovarian transposition in gynaecological cancers; a systematic review and meta-analysis. J Ovarian Res 7(1):69","journal-title":"J Ovarian Res"},{"issue":"3","key":"5554_CR48","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ygyno.2006.03.050","volume":"102","author":"I Vistad","year":"2006","unstructured":"Vistad I, Fossa SD, Dahl AA (2006) A critical review of patient-rated quality of life studies of long-term survivors of cervical cancer. Gynecol Oncol 102(3):563\u2013572","journal-title":"Gynecol Oncol"},{"issue":"1","key":"5554_CR49","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.clinthera.2014.11.013","volume":"37","author":"KS Pfaendler","year":"2015","unstructured":"Pfaendler KS, Wenzel L, Mechanic MB, Penner KR (2015) Cervical cancer survivorship: long-term quality of life and social support. Clin Ther 37(1):39\u201348","journal-title":"Clin Ther"},{"key":"5554_CR50","doi-asserted-by":"crossref","first-page":"795","DOI":"10.2147\/IJWH.S143368","volume":"9","author":"S Klugel","year":"2017","unstructured":"Klugel S et al (2017) Concomitant psychiatric symptoms and impaired quality of life in women with cervical cancer: a critical review. Int J Women's Health 9:795\u2013805","journal-title":"Int J Women's Health"},{"issue":"7","key":"5554_CR51","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/IGC.0000000000000207","volume":"24","author":"S Ye","year":"2014","unstructured":"Ye S, Yang J, Cao D, Lang J, Shen K (2014) A systematic review of quality of life and sexual function of patients with cervical cancer after treatment. Int J Gynecol Cancer 24(7):1146\u20131157","journal-title":"Int J Gynecol Cancer"},{"key":"5554_CR52","first-page":"E649","volume":"22","author":"E Lammerink","year":"2012","unstructured":"Lammerink E et al (2012) Sexual functioning of cervical cancer survivors: a review with a female perspective. Int J Gynecol Cancer 22:E649","journal-title":"Int J Gynecol Cancer"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-020-05554-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-020-05554-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-020-05554-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T23:36:35Z","timestamp":1623972995000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-020-05554-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,18]]},"references-count":52,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["5554"],"URL":"https:\/\/doi.org\/10.1007\/s00520-020-05554-2","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,18]]},"assertion":[{"value":"4 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"MT reports travel support from Roche, outside the submitted work. RMB reports UCB project funding, outside the submitted work. The other authors have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}